Skip to main content
European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS

SUPporting high quality evaluation of COVID-19 convalescent Plasma thrOughoutT Europe

Livrables

D3.4 Dashboard report

Dashboard report

D2.7 Assessment report on data quality and number of complete datasets

Assessment report on data quality and number of complete datasets

D7.1 Composition of the Scientific and Ethics Advisory Board

Composition of the Scientific and Ethics Advisory Board.

D2.6 Status report: SUPPORT-E funding of clinical trials in need.

Status report SUPPORTE funding of clinical trials in need

D1.1 Status report of EU and International ongoing/upcoming clinical trials

Status report of EU and International ongoing/upcoming clinical trials.

D2.13 Assessment report on data quality and number of complete datasets

Assessment report on data quality and number of complete datasets

D1.4 Status report of international ongoing clinical trials

Status report of international ongoing clinical trials.

D2.12 Status report: SUPPORT-E funding of clinical trials in need

Status report SUPPORTE funding of clinical trials in need

D7.3 Ethics review final report

Ethics review final report

D2.9 Status report: SUPPORT-E funding of clinical trials in need

Status report SUPPORTE funding of clinical trials in need

D1.3 Preliminary guidance document for monitored access

Preliminary guidance document for monitored access.

D2.15 Status report: SUPPORT-E funding of clinical trials in need.

Status report: SUPPORT-E funding of clinical trials in need.

D6.6 Technical report for laypersons

Technical report for laypersons.A technical report (final) for laypersons (brochure) will be produced in order to describe the partners’ conclusions and achievements highlighting the methodology used and describing the recommended implementation process among EU Member States.

D4.4 Standardized quantitative and qualitative results on antibody content of all individual plasmas administered in hospitals linked to participating EBA members

Standardized quantitative and qualitative results on antibody content of all individual plasmas administered in hospitals linked to participating EBA members

D7.2 Ethics review mid report

Ethics review mid report.

D5.2 Recommendations report

Interim Report and recommendations

D2.2 Status report: SUPPORT-E funding of clinical trials in need

Status report SUPPORTE funding of clinical trials in need

D5.3 Final Recommendations Report

Interim report and recommendations.

D4.2 Access to tests that qualify CP for clinical studies across Europe is assured for BE in need

Access to tests that qualify CP for clinical studies across Europe is assured for BE in need.

D7.4 Ethics review final report

Ethics review final report.

D2.8 Status report: interactions with supported clinical trials and monitored access programmes

Status report interactions with supported clinical trials and monitored access programmes

D2.11 Status report: interactions with supported clinical trials and monitored access programmes

Status report interactions with supported clinical trials and monitored access programmes

D1.6 Status report of international ongoing clinical trials

Status report of international ongoing clinical trials

D2.14 Analysis report on database data and novel generated data

Analysis report on database data and novel generated data

D2.4 Status report: interactions with supported clinical trials and monitored access programmes

Status report interactions with supported clinical trials and monitored access programmes

D4.1 Variability between tests across Europe mapped so standardization and calibration possible

Variability between tests across Europe mapped so standardization and calibration possible .

D1.5 Status report of international ongoing clinical trials

Status report of international ongoing clinical trials.

D2.1 Status report: interactions with supported clinical trials and monitored access programmes

Status report interactions with supported clinical trials and monitored access programmes

D2.10 Assessment report on data quality and number of complete datasets

Assessment report on data quality and number of complete datasets

D4.3 PoC of test measuring in vitro virus neutralizing activity on ELISA basis

PoC of test measuring in vitro virus neutralizing activity on ELISA basis.

D5.1 Recommendations report

Interim report and recommendations

D3.1 Dashboard report

Dashboard report.

D6.4 Technical report for laypersons

Technical report for laypersons.A technical report (interim) for laypersons (brochure) will be produced in order to describe the partners’ conclusions and achievements highlighting the methodology used and describing the recommended implementation process among EU Member States

D2.5 Status report: interactions with supported clinical trials and monitored access programmes

Status report interactions with supported clinical trials and monitored access programmes

D2.3 Assessment report on data quality and number of complete datasets

Assessment report on data quality and number of complete datasets

D1.2 Preliminary guidance document with assessment criteria for clinical trials

Preliminary guidance document with assessment criteria for clinical trials.

D3.2 Data analysis report and statistical power calculations

Data analysis report and statistical power calculations

Publications

Characterization of the SARS-CoV-2 Neutralization Potential of COVID-19–Convalescent Donors

Auteurs: Bernd Jahrsdörfer, Rüdiger Groß, Alina Seidel, Lukas Wettstein, Carolin Ludwig, Tatjana Schwarz, Sixten Körper, Markus Rojewski, Ramin Lotfi, Christoph Weinstock, Erhard Seifried, Victor Max Corman, Christian Drosten, Jan Münch, Hubert Schrezenmeier
Publié dans: The Journal of Immunology, Numéro 206/11, 2021, Page(s) 2614-2622, ISSN 0022-1767
Éditeur: American Association of Immunologists
DOI: 10.4049/jimmunol.2100036

BNT162b2 Booster Vaccination Elicits Cross-Reactive Immunity Against SARS-CoV-2 Variants B.1.1.529 and B.1.617.2 in Convalescents of All Ages.

Auteurs: Jahrsdörfer B, Proffen M, Scholz J, Hägele J, Ludwig C, Vieweg C, Grempels A, Fabricius D, Lotfi R, Körper S, Adler G, Schrezenmeier H.
Publié dans: Frontiers in Immunology, 2022, ISSN 1664-3224
Éditeur: Lausanne: Frontiers Media S.A., 2010-
DOI: 10.3389/fimmu.2022.920210

B Cell Numbers Predict Humoral and Cellular Response Upon SARS-CoV-2 Vaccination Among Patients Treated With Rituximab

Auteurs: Stefanski AL, Rincon-Arevalo H, Schrezenmeier E, Karberg K, Szelinski F, Ritter J, Jahrsdörfer B, Schrezenmeier H, Ludwig C, Sattler A, Kotsch K, Chen Y, Claußnitzer A, Haibel H, Proft F, Guerra G, Durek P, Heinrich F, Ferreira-Gomes M, Burmester GR, Radbruch A, Mashreghi MF, Lino AC, Dörner T.
Publié dans: Arthritis Rheumatol, 2022, ISSN 2326-5191
Éditeur: Arthritis Rheumatol
DOI: 10.1002/art.42060

B Cell Characteristics at Baseline Predict Vaccination Response in RTX Treated Patients

Auteurs: Stefanski AL, Rincon-Arevalo H, Schrezenmeier E, Karberg K, Szelinski F, Ritter J, Chen Y, Jahrsdörfer B, Ludwig C, Schrezenmeier H, Lino AC, Dörner T
Publié dans: Frontier of Immunology, 2022, ISSN 1664-3224
Éditeur: Lausanne: Frontiers Media S.A., 2010-
DOI: 10.3389/fimmu.2022.822885

B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients

Auteurs: Schrezenmeier E, Rincon-Arevalo H, Stefanski AL, Potekhin A, Straub-Hohenbleicher H, Choi M, Bachmann F, Pross V, Hammett C, Schrezenmeier H, Ludwig C, Jahrsdörfer B, Lino A, Eckardt KU, Kotsch K, Dörner T, Budde K, Sattler A, Halleck F
Publié dans: J Am Soc Nephrol, 2021, ISSN 1533-3450
Éditeur: Journal of the American Society of Nephrology
DOI: 10.1681/asn.2021070966

A novel competition ELISA for the rapid quantification of SARS-CoV-2 neutralizing antibodies in convalescent plasma.

Auteurs: Elise Wouters; Caro Verbrugghe; Rosalie Devloo; Isabelle Debruyne; Dorien De Clippel; Leen Van Heddegem; Kristin Van Asch; Véronique Van Gaver; Miek Vanbrabant; An Muylaert; Veerle Compernolle; Hendrik B. Feys
Publié dans: TRANSFUSION, Numéro 2, 2021, ISSN 0041-1132
Éditeur: Blackwell Publishing Inc.
DOI: 10.1111/trf.16652

Hyperimmune immunoglobulin for people with COVID‐19

Auteurs: Kimber C, Valk SJ, Chai KL, Piechotta V, Iannizzi C, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N.
Publié dans: The Cochrane Database of Systematic Reviews, 2023, Page(s) CD015167, ISSN 1465-1858
Éditeur: The Cochrane Database of Systematic Reviews
DOI: 10.1002/14651858.cd015167.pub2

Effects of SARS-CoV-2 strain variation on virus neutralisation titres: therapeutic use of convalescent plasma.

Auteurs: Dung Nguyen; Julie Xiao; Peter Simmonds; Abigail Lamikanra; Valerie Odon; Jeremy Ratcliff; Alain Townsend; Alain Townsend; David J. Roberts; David J. Roberts; H. Harvala; H. Harvala
Publié dans: The journal of infectious diseases, Numéro 2, 2021, ISSN 1537-6613
Éditeur: The journal of infectious diseases.
DOI: 10.1093/infdis/jiab563

Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination-specific humoral and cellular immunity in kidney transplant recipients.

Auteurs: Schrezenmeier E, Rincon-Arevalo H, Jens A, Stefanski AL, Hammett C, Osmanodja B, Koch N, Zukunft B, Beck J, Oellerich M, Proß V, Stahl C, Choi M, Bachmann F, Liefeldt L, Glander P, Schütz E, Bornemann-Kolatzki K, López Del Moral C, Schrezenmeier H, Ludwig C, Jahrsdörfer B, Eckardt KU, Lachmann N, Kotsch K, Dörner T, Halleck F, Sattler A, Budde K.
Publié dans: JCI Insight, 2022, ISSN 2379-3708
Éditeur: JCI Insight
DOI: 10.1172/jci.insight.157836

Evaluation of SARS‐CoV‐2 antibody titers and potency for convalescent plasma donation: a brief commentary

Auteurs: Elise Wouters, Maurice Steenhuis, Hubert Schrezenmeier, Pierre Tiberghien, Heli Harvala, Hendrik B. Feys, Ellen Schoot
Publié dans: Vox Sanguinis, Numéro 116/5, 2021, Page(s) 493-496, ISSN 0042-9007
Éditeur: Blackwell Publishing Inc.
DOI: 10.1111/vox.13060

Dynamics of antibodies to SARS-CoV-2 in convalescent plasma donors

Auteurs: Steenhuis, Maurice; van Mierlo, Gerard; Derksen, Ninotska Il; Ooijevaar-de Heer, Pleuni; Kruithof, Simone; Loeff, Floris L; Berkhout, Lea C; Linty, Federica; Reusken, Chantal; Reimerink, Johan; Hogema, Boris; Zaaijer, Hans; van de Watering, Leo; Swaneveld, Francis; van Gils, Marit J; Bosch, Berend Jan; van Ham, S Marieke; Ten Brinke, Anja; Vidarsson, Gestur; van der Schoot, Ellen C; Rispens, Theo;
Publié dans: VOLUME=10;ISSUE=5;TITLE=Clinical & translational immunology, Numéro 2, 2021, ISSN 2050-0068
Éditeur: John Wiley & Sons Australia, Ltd
DOI: 10.1002/cti2.1285

Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients

Auteurs: Arne Sattler, Eva Schrezenmeier, Ulrike A. Weber, Alexander Potekhin, Friederike Bachmann, Henriette Straub-Hohenbleicher, Klemens Budde, Elena Storz, Vanessa Proß, Yasmin Bergmann, Linda M.L. Thole, Caroline Tizian, Oliver Hölsken, Andreas Diefenbach, Hubert Schrezenmeier, Bernd Jahrsdörfer, Tomasz Zemojtel, Katharina Jechow, Christian Conrad, Sören Lukassen, Diana Stauch, Nils Lachmann, Mira
Publié dans: Journal of Clinical Investigation, Numéro 131/14, 2021, ISSN 1558-8238
Éditeur: American Society for Clinical Investigation
DOI: 10.1172/jci150175

SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data

Auteurs: Dung Nguyen, Peter Simmonds, Maurice Steenhuis, Elise Wouters, Daniel Desmecht, Mutien Garigliany, Marta Romano, Cyril Barbezange, Piet Maes, Bram Van Holm, Joaquín Mendoza, Salvador Oyonarte, Anders Fomsgaard, Ria Lassaunière, Eva Zusinaite, Katarina Resman Rus, Tatjana Avšič-Županc, Johan HJ Reimerink, Fiona Brouwer, Marieke Hoogerwerf, Chantal BEM Reusken, Gunnveig Grodeland, Sophie Le Cam
Publié dans: Eurosurveillance, Numéro 26/27, 2021, ISSN 1560-7917
Éditeur: European Center for Disease Prevention and Control
DOI: 10.2807/1560-7917.es.2021.26.27.2100568

Convalescent plasma donors show enhanced cross-reactive neutralizing antibody response to antigenic variants of SARS-CoV-2 following immunization

Auteurs: Heli Harvala; Dung Nguyen; Peter Simmonds; Abigail A. Lamikanra; Hoi Pat Tsang; Ashley Otter; Piet Maes; Mhairi Webster; Adam Clarkson; Fotini Kaloyirou; Valerie Hopkins; Stephen M. Laidlaw; Miles Carroll; Ana Mora; Alexandra Griffiths; Sheila MacLennan; Lise Estcourt; David J. Roberts
Publié dans: Transfusion, Numéro 1, 2022, ISSN 0041-1132
Éditeur: Blackwell Publishing Inc.
DOI: 10.1111/trf.16934

BNT162b2 Vaccination Elicits Strong Serological Immune Responses Against SARS-CoV-2 Including Variants of Concern in Elderly Convalescents

Auteurs: Jahrsdörfer B, Fabricius D, Scholz J, Ludwig C, Grempels A, Lotfi R, Körper S, Adler G, Schrezenmeier H
Publié dans: Front Immunol, 2021, ISSN 1664-3224
Éditeur: Lausanne: Frontiers Media S.A., 2010-
DOI: 10.3389/fimmu.2021.743422

A novel competition ELISA for the selection of COVID-19 convalescent plasma donors

Auteurs: Verbrugghe, C; Wouters, E; Compernolle, V; Feys, H.B.
Publié dans: 2021
Éditeur: Ghent University Press

Recherche de données OpenAIRE...

Une erreur s’est produite lors de la recherche de données OpenAIRE

Aucun résultat disponible